Renal Diseases Market Growth Opportunities and Forecast by 2034

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034

Coverage: Renal Diseases Market covers analysis By Disease Type ( Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Disease ); Treatment Type ( Dialysis, Medication, Kidney Transplantation, Surgery, Diet, Others ); Diagnosis ( Blood tests, Imaging Tests, Biopsy, Urine tests, Others ); End User ( Dialysis Centers, Hospital and Clinics, Research and Academic Institutes ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Feb 2026
  • Report Code : TIPRE00017692
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Renal Diseases Market is anticipated to expand at a CAGR of 5.41% from 2026 to 2034. Market conditions continue to evolve, leading to new opportunities for stakeholders. The overall landscape reflects stable progress and long-term growth potential.

The report is segmented by Disease Type (Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Disease); Treatment Type (Dialysis, Medication, Kidney Transplantation, Surgery, Diet, Others); Diagnosis (Blood tests, Imaging Tests, Biopsy, Urine tests, Others) and End User (Dialysis Centers, Hospital and Clinics, Research and Academic Institutes). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Renal Diseases Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Renal Diseases Market Segmentation Disease Type

  1. Chronic Kidney Disease
  2. End-Stage Renal Disease
  3. Acute Kidney Disease

Treatment Type

  1. Dialysis
  2. Medication
  3. Kidney Transplantation
  4. Surgery
  5. Diet

Diagnosis

  1. Blood tests
  2. Imaging Tests
  3. Biopsy
  4. Urine tests

End User

  1. Dialysis Centers
  2. Hospital and Clinics
  3. Research and Academic Institutes
Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Renal Diseases Market: Strategic Insights

renal-diseases-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Renal Diseases Market Growth Drivers

  1. Increasing Prevalence of Chronic Kidney Disease (CKD): The rising prevalence of chronic kidney disease (CKD) is one of the most significant growth drivers for the renal diseases market. Kidney-related disorders including CKD are becoming more common as people around the world grow older. The leading factors of CKD include diabetes and hypertension together with obesity which are both rising in global prevalence. The World Health Organization (WHO) now considers CKD an urgent public health challenge because it leads to several fatal complications like cardiovascular disease. While developed countries see growing CKD rates in aging populations developed nations witness higher CKD cases among older people while developing regions experience kidney disease spikes due to rising diabetes and hypertension cases. Early detection and management of CKD helps slow disease progression which creates higher demand for renal disease treatments and monitoring solutions. The renal diseases market is experiencing significant growth because healthcare systems are now emphasizing early diagnosis along with individualized treatment methods to enhance patient outcomes. Non-invasive diagnostic methods like biomarker tests and imaging help detect kidney problems earlier which boosts demand for pharmaceuticals and treatments targeting kidney function and management. The renal diseases market growth is anticipated because CKD global prevalence keeps increasing which creates more demand for dialysis services, renal transplantation, and medications for kidney diseases.
  2. Advances in Dialysis Technologies: Developments in dialysis technologies act as a vital growth factor for the market addressing renal diseases. Hemodialysis and peritoneal dialysis stand as fundamental treatments for patients suffering from end-stage renal disease (ESRD). As more CKD patients advance to ESRD the requirement for dialysis services and products continues to expand. New technologies in dialysis machines and procedures have led to better patient results while shortening dialysis treatment times and improving patient comfort during process. New portable dialysis devices now allow patients to receive treatments in their homes which increases convenience and diminishes the necessity for hospital visits. Upgrades to dialyzersReport Scope

    Renal Diseases Market Regional Insights

    The regional trends and factors influencing the Renal Diseases Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Renal Diseases Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Renal Diseases Market Report Scope

    By Treatment Type
    • Dialysis
    • Medication
    • Kidney Transplantation
    • Surgery
    • Diet
    By Diagnosis
    • Blood tests
    • Imaging Tests
    • Biopsy
    • Urine tests
    By End User
    • Dialysis Centers
    • Hospital and Clinics
    • Research and Academic Institutes
    Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
    South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
    Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
    Report Attribute Details
    Market size in 2025 US$ XX Million
    Market Size by 2034 US$ XX Million
    Global CAGR (2026 - 2034) 5.41%
    Historical Data 2021-2024
    Forecast period 2026-2034
    Segments Covered By Disease Type
    • Chronic Kidney Disease
    • End-Stage Renal Disease
    • Acute Kidney Disease
    Regions and Countries Covered North America
    • US
    • Canada
    • Mexico
    Market leaders and key company profiles
    • Abbott, 
    • Amgen Inc.
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline PLC
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.

    Renal Diseases Market Players Density: Understanding Its Impact on Business Dynamics

    The Renal Diseases Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    renal-diseases-market-cagr
    • Get the Renal Diseases Market top key players overview

Frequently Asked Questions

1

What is the expected CAGR of the Renal Diseases Market?

The Renal Diseases Market is estimated to witness a CAGR of 5.41% from 2025 to 2031.
2

What are the driving factors impacting the Renal Diseases Market?

The major factors driving the Renal Diseases Market are Increasing Prevalence of Chronic Kidney Disease (CKD), Advances in Dialysis Technologies, and Growing Awareness and Early Detection of Kidney Disease.
3

What are the future trends of the Renal Diseases Market?

Future trends in the Renal Diseases Market are Growing Focus on Preventative Care and Early Intervention, Increased Adoption of Telemedicine in Renal Disease Management, and Growth of Home-Based Dialysis Solutions.
4

Which are the leading players in the Renal Diseases Market?

Some of the players operating in the market are Abbott, Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC,Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd.
5

What are the deliverable formats of the Renal Diseases Market report?

The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
6

What are the options available for the customization of this report?

Some customization options available based on the request are an additional 3-5 company profiles and a country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA